MARY PAUL to Pyridones
This is a "connection" page, showing publications MARY PAUL has written about Pyridones.
Connection Strength
0.147
-
Safety and pharmacokinetics of oral and long-acting injectable cabotegravir or long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study. Lancet HIV. 2024 04; 11(4):e211-e221.
Score: 0.096
-
Birth outcomes following bictegravir exposure during pregnancy. AIDS. 2025 Mar 15; 39(4):381-386.
Score: 0.050